Cassidy Bio is a healthcare startup focused on harnessing artificial intelligence to revolutionize genome editing. Founded in 2024, the company aims to develop safer, scalable gene editing therapies, transforming years of trial-and-error into predictive, therapeutic-grade designs. Leveraging a genomic foundation model that incorporates diverse human genome data, Cassidy Bio provides end-to-end solutions for gene editing, from guide design to outcome prediction, ensuring faster and more reliable therapeutic advancements.

Cassidy Bio(קסידי ביו בע~מ)

Cassidy Bio(קסידי ביו בע~מ)